Creative Planning Has $869,000 Stake in Amdocs Limited (NASDAQ:DOX)

Creative Planning grew its holdings in Amdocs Limited (NASDAQ:DOX) by 122.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,007 shares of the technology company’s stock after acquiring an additional 6,069 shares during the quarter. Creative Planning’s holdings in Amdocs were worth $869,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of DOX. Pzena Investment Management LLC boosted its stake in Amdocs by 33.2% in the 2nd quarter. Pzena Investment Management LLC now owns 5,667,603 shares of the technology company’s stock worth $447,287,000 after purchasing an additional 1,412,826 shares during the period. Vanguard Group Inc. boosted its position in shares of Amdocs by 39.5% during the first quarter. Vanguard Group Inc. now owns 2,033,536 shares of the technology company’s stock worth $183,771,000 after buying an additional 576,168 shares during the period. Pacer Advisors Inc. boosted its position in shares of Amdocs by 36.2% during the second quarter. Pacer Advisors Inc. now owns 1,675,784 shares of the technology company’s stock worth $132,253,000 after buying an additional 444,966 shares during the period. Acadian Asset Management LLC grew its holdings in shares of Amdocs by 22.7% during the first quarter. Acadian Asset Management LLC now owns 1,395,894 shares of the technology company’s stock worth $126,119,000 after buying an additional 258,343 shares in the last quarter. Finally, LSV Asset Management raised its position in Amdocs by 7.9% in the 2nd quarter. LSV Asset Management now owns 3,207,155 shares of the technology company’s stock valued at $253,109,000 after buying an additional 234,096 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Up 0.5 %

NASDAQ:DOX opened at $88.25 on Friday. Amdocs Limited has a twelve month low of $74.41 and a twelve month high of $94.04. The firm has a market capitalization of $10.37 billion, a price-to-earnings ratio of 19.83, a price-to-earnings-growth ratio of 1.42 and a beta of 0.74. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.21. The stock’s 50 day moving average price is $85.64 and its two-hundred day moving average price is $83.60.

Amdocs (NASDAQ:DOX) last issued its earnings results on Wednesday, August 7th. The technology company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.02. The business had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.25 billion. Amdocs had a net margin of 10.21% and a return on equity of 17.89%. The firm’s revenue for the quarter was up 1.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.41 earnings per share. Equities research analysts expect that Amdocs Limited will post 5.67 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be issued a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a yield of 2.17%. The ex-dividend date is Monday, September 30th. Amdocs’s payout ratio is currently 42.92%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on DOX shares. StockNews.com raised Amdocs from a “buy” rating to a “strong-buy” rating in a research report on Thursday. Stifel Nicolaus started coverage on shares of Amdocs in a report on Wednesday, October 2nd. They set a “buy” rating and a $100.00 target price for the company. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $102.00.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.